Basic Information
| Terpenoid ID | TKC066096 |
|
| Cell line | 0 | |
| Protein target | 52 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 135 |
| Terpenoid ID | TKC066096 |
|
| Cell line | 0 | |
| Protein target | 52 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 135 |
| ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
|---|---|---|---|---|---|---|---|
| TKC066096 | HepG2 | 3162.0 | nM | Potency | C3728 | Orphanet_449 | |
| TKC066096 | CHO | Chinese Hamster Ovary; CHO-ori | 619.0 | nM | IC50 | ||
| TKC066096 | HEK293 | 22387.0 | nM | Potency | |||
| TKC066096 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 1430.0 | nM | CC50 | ||
| TKC066096 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 14.0 | nM | GI50 | C3242 | Orphanet_29073 |
| TKC066096 | HT-29 | HT 29; HT29 | 1.0 | ug.mL-1 | IC50 | C4349 | |
| TKC066096 | A549 | 690.0 | nM | IC50 | C3512 | ||
| TKC066096 | MCF7 | 153.0 | nM | IC50 | C4194 | ||
| TKC066096 | RAW264.7 | RAW264 | 230.0 | nM | IC50 | C21604 | |
| TKC066096 | P388 | P-388 | 4.0 | ug ml-1 | ED50 | C21602 | |
| TKC066096 | HT-1080 | Ht-1080; HT 1080; HT1080; HT 1080.T | 1.0 | ug ml-1 | ED50 | C3043 | Orphanet_2030 |
| TKC066096 | Lu1 | Lu1 | 1.0 | ug ml-1 | ED50 | C21678 | |
| TKC066096 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 1.0 | ug ml-1 | ED50 | C3224 | |
| TKC066096 | A-431 | A431; A431/P | 2.0 | ug ml-1 | ED50 | C4819 | |
| TKC066096 | LNCaP | LNCAP; LNCap; Ln-Cap; Lymph Node Carcinoma of the prostate | 2500.0 | nM | IC50 | C4863 | |
| TKC066096 | SH-SY5Y | SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental | 38.0 | nM | EC50 | C3270 | Orphanet_635 |
| TKC066096 | SK-N-SH | SK N SH; SKN-SH; SK-NSH; SKNSH; NSH | 24.0 | % | Activity | C3270 | Orphanet_635 |
| TKC066096 | HeLa | HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri | 840.0 | nM | IC50 | C27677 | |
| TKC066096 | PC-12 | PC 12; PC12 | 3150.0 | nM | IC50 | C5650 | |
| TKC066096 | SW-620 | SW-620; SW 620; SW.620 | 99.0 | % | Activity | C4349 | |
| TKC066096 | THP-1 | THP1; THP 1; THPI; THP-1(ATCC); THP-1-O; O-THP-1; Tohoku Hospital Pediatrics-1 | 15000.0 | nM | EC50 | C9163 | Orphanet_514 |
| TKC066096 | HEK-293T | Hek293T; HEK-293T; HEK 293T; HEK-293-T; HEK 293 T; 293-T; 293 T; 293T; Human Embryonic Kidney 293T; 293tsA1609neo | 670.0 | nM | IC50 | ||
| TKC066096 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 149.0 | nM | GI50 | C4450 | |
| TKC066096 | SN12C | SN-12C | 38.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC066096 | MDA-N | MDAN | 23.0 | nM | GI50 | C3802 | |
| TKC066096 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 53.0 | nM | GI50 | C3512 | |
| TKC066096 | ACHN | 17.0 | nM | GI50 | C6975 | Orphanet_319298 | |
| TKC066096 | UO-31 | UO.31; UO31; U031 | 31.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC066096 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 10.0 | nM | GI50 | C2926 | |
| TKC066096 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 1000.0 | nM | IC50 | C9154 | Orphanet_519 |
| TKC066096 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 81.0 | nM | GI50 | C3796 | Orphanet_251576 |
| TKC066096 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 67.0 | nM | GI50 | C4863 | |
| TKC066096 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 70.0 | nM | GI50 | C3510 | |
| TKC066096 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 35.0 | nM | GI50 | C3224 | |
| TKC066096 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 20.0 | nM | GI50 | C9110 | Orphanet_521 |
| TKC066096 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 1930.0 | nM | IC50 | C105555 | |
| TKC066096 | A498 | A498 | 34.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC066096 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 237.0 | nM | GI50 | C3512 | |
| TKC066096 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 12.0 | nM | GI50 | C9142 | Orphanet_99861 |
| TKC066096 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 25.0 | nM | GI50 | C105555 | |
| TKC066096 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 30.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC066096 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 23.0 | nM | GI50 | C105555 | |
| TKC066096 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 180.0 | nM | GI50 | C105555 | |
| TKC066096 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 76.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC066096 | SR | SR-786; SR786 | 10.0 | nM | GI50 | C37193 | Orphanet_300895 |
| TKC066096 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 1320.0 | nM | IC50 | C5214 | |
| TKC066096 | TK-10 | TK.10; TK 10; TK10 | 11.0 | nM | GI50 | C4033 | Orphanet_319276 |
| TKC066096 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 14.0 | nM | GI50 | C3512 | |
| TKC066096 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 45.0 | nM | GI50 | C3802 | |
| TKC066096 | KM12 | KM-12; KM.12 | 169.0 | nM | GI50 | C4910 | |
| TKC066096 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 528.0 | nM | GI50 | C2923 | |
| TKC066096 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 19.0 | nM | GI50 | C105555 | |
| TKC066096 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 18.0 | nM | GI50 | C3802 | |
| TKC066096 | BT-549 | BT 549; BT.549; BT549 | 12.0 | nM | GI50 | C4194 | |
| TKC066096 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 132.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC066096 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 31.0 | nM | GI50 | C4349 | |
| TKC066096 | HCT-15 | HCT-15; HCT.15; HCT15 | 11.0 | nM | GI50 | C4349 | |
| TKC066096 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 5260.0 | nM | IC50 | C4910 | |
| TKC066096 | SF-268 | SF-268; SF.268; SF 268 | 45.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC066096 | EKVX | 47.0 | nM | GI50 | C3512 | ||
| TKC066096 | T47D | 20.0 | nM | GI50 | C4194 | ||
| TKC066096 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 1680.0 | nM | IC50 | C7978 | |
| TKC066096 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 24.0 | nM | GI50 | C3224 | |
| TKC066096 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 35.0 | nM | GI50 | C3802 | |
| TKC066096 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 13.0 | nM | GI50 | C3224 | |
| TKC066096 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 18.0 | nM | GI50 | C7979 | Orphanet_454723 |
| TKC066096 | SF-295 | SF-295; SF.295; SF 295 | 194.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC066096 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 43.0 | nM | GI50 | C4194 | |
| TKC066096 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 15.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC066096 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 10.0 | nM | GI50 | C7953 | Orphanet_99861 |
| TKC066096 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 26.0 | nM | GI50 | C3224 | |
| TKC066096 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 160.0 | nM | GI50 | C45662 | Orphanet_50251 |
| TKC066096 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 16.0 | nM | GI50 | C3510 | |
| TKC066096 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 17.0 | nM | GI50 | C4349 | |
| TKC066096 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 11.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC066096 | HepG2 | 580.0 | nM | IC50 | C3728 | Orphanet_449 | |
| TKC066096 | MGC-803 | MGC803; MGc80-3 | 1550.0 | nM | IC50 | C5248 | |
| TKC066096 | Bel-7402 | Bel-7402; BEL 7402; Bel 7402; BEL7402; Bel7402 | 440.0 | nM | IC50 | C27677 | |
| TKC066096 | SGC-7901 | SGC 7901; SGC7901 | 870.0 | nM | IC50 | C27677 | |
| TKC066096 | MIA PaCa-2 | MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa | 460.0 | nM | IC50 | C9120 | |
| TKC066096 | BJ | 2740.0 | nM | IC50 | |||
| TKC066096 | SK-BR-3 | SK-Br-3; Sk-Br-3; SK BR 03; SKBR-3; SKBr-3; SK-BR3; SKBr3; SkBr3; SKBR3 | 720.0 | nM | IC50 | C5214 | |
| TKC066096 | HEK293 | 837.0 | nM | CC50 | |||
| TKC066096 | HOS | 930.0 | nM | IC50 | C9145 | Orphanet_668 | |
| TKC066096 | A2780 | A-2780; 2780; A2780S; A2780par | 1840.0 | nM | IC50 | C7979 | Orphanet_454723 |
| TKC066096 | PANC-1 | Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P | 3000.0 | nM | IC50 | C9120 |
| ID | Uniport | Pref_name | Gene name | value | unit | type |
|---|---|---|---|---|---|---|
| TKC066096 | P11473 | Vitamin D3 receptor | VDR | 28184 | nM | Potency |
| TKC066096 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 1032 | nM | Potency |
| TKC066096 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 2100 | nM | IC50 |
| TKC066096 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | 18800 | nM | IC50 |
| TKC066096 | P07900 | Heat shock protein HSP 90-alpha | HSP90AA1 | 1408 | nM | AC50 |
| TKC066096 | P07900 | Heat shock protein HSP 90-alpha | HSP90AA1 | 12 | % | Inhibition |
| TKC066096 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 91 | % | Inhibition |
| TKC066096 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 147 | % | Inhibition |
| TKC066096 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 4611 | nM | Potency |
| TKC066096 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 50119 | nM | Potency |
| TKC066096 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 1000 | nM | Potency |
| TKC066096 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 2119 | nM | Potency |
| TKC066096 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 1995 | nM | Potency |
| TKC066096 | Q06710 | Paired box protein Pax-8 | PAX8 | 2410 | nM | AC50 |
| TKC066096 | Q14191 | Werner syndrome ATP-dependent helicase | WRN | 24149 | nM | Potency |
| TKC066096 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 18356 | nM | Potency |
| TKC066096 | Q77YF9 | Protein Vpr | vpr | 56234 | nM | Potency |
| TKC066096 | Q932Y6 | Beta-lactamase | bla(tem-2) | 21433 | nM | IC50 |
| TKC066096 | Q99700 | Ataxin-2 | ATXN2 | 5623 | nM | Potency |
| TKC066096 | O75164 | Lysine-specific demethylase 4A | KDM4A | 19953 | nM | Potency |
| TKC066096 | Q9UBT6 | DNA polymerase kappa | POLK | 31623 | nM | Potency |
| TKC066096 | Q9UNA4 | DNA polymerase iota | POLI | 3548 | nM | Potency |
| TKC066096 | O75496 | Geminin | GMNN | 731 | nM | Potency |
| TKC066096 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 19953 | nM | Potency |
| TKC066096 | P01215 | Glycoprotein hormones alpha chain | CGA | 2239 | nM | Potency |
| TKC066096 | P37840 | Alpha-synuclein | SNCA | 35481 | nM | Potency |
| TKC066096 | P39748 | Flap endonuclease 1 | FEN1 | 39811 | nM | Potency |
| TKC066096 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | PIN1 | 53582 | nM | Potency |
| TKC066096 | O42275 | Acetylcholinesterase | ache | 22 | % | Inhibition |
| TKC066096 | P81908 | Cholinesterase | BCHE | 1 | % | Inhibition |
| TKC066096 | P83916 | Chromobox protein homolog 1 | CBX1 | 19953 | nM | Potency |
| TKC066096 | P54132 | Bloom syndrome protein | BLM | 21523 | nM | Potency |
| TKC066096 | O14746 | Telomerase reverse transcriptase | TERT | 780 | nM | IC50 |
| TKC066096 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | PTPN6 | 3100 | nM | IC50 |
| TKC066096 | P29990 | Genome polyprotein | 19660 | nM | IC50 | |
| TKC066096 | P49798 | Regulator of G-protein signaling 4 | RGS4 | 11220 | nM | Potency |
| TKC066096 | Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | PTPN11 | 3300 | nM | IC50 |
| TKC066096 | Q9Y253 | DNA polymerase eta | POLH | 7943 | nM | Potency |
| TKC066096 | O94925 | Glutaminase kidney isoform, mitochondrial | GLS | 5012 | nM | Potency |
| TKC066096 | P0C6X7 | Replicase polyprotein 1ab | rep | 4200 | nM | Ki |
| TKC066096 | P0C6X7 | Replicase polyprotein 1ab | rep | 10300 | nM | IC50 |
| TKC066096 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | USP2 | 28700 | nM | IC50 |
| TKC066096 | P51684 | C-C chemokine receptor type 6 | CCR6 | 31800 | nM | IC50 |
| TKC066096 | P22736 | Nuclear receptor subfamily 4 group A member 1 | NR4A1 | 290 | nM | Kd |
| TKC066096 | Q548M1 | 60 kDa chaperonin | groL | 63 | % | Inhibition |
| TKC066096 | Q00613 | Heat shock factor protein 1 | HSF1 | 1100 | nM | EC50 |
| TKC066096 | P23469 | Receptor-type tyrosine-protein phosphatase epsilon | PTPRE | >500000 | nM | IC50 |
| TKC066096 | P35236 | Tyrosine-protein phosphatase non-receptor type 7 | PTPN7 | 75700 | nM | IC50 |
| TKC066096 | Q8VNN2 | Beta-galactosidase | lacZ | >66600 | nM | IC50 |
| TKC066096 | Q8IL32 | Heat shock protein 90, putative | PF3D7_1443900 | 1481 | nM | AC50 |
| TKC066096 | P04608 | Protein Tat | tat | >100000 | nM | IC50 |
| TKC066096 | P11413 | Glucose-6-phosphate 1-dehydrogenase | G6PD | >80000 | nM | IC50 |
| TKC066096 | Q57TT1 | HpcH_HpaI domain-containing protein | Tb08.30K1.730 | 35481 | nM | Potency |
| TKC066096 | Q9BHT9 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | G6PD-6PGL | 16700 | nM | IC50 |
| TKC066096 | Q9NR96 | Toll-like receptor 9 | TLR9 | 3015 | nM | IC50 |
| TKC066096 | E9QYP0 | L-ornithine N | sidA | 1400 | nM | Kd |
| TKC066096 | P60484 | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN | PTEN | 13300 | nM | IC50 |
| TKC066096 | Q12913 | Receptor-type tyrosine-protein phosphatase eta | PTPRJ | 111500 | nM | IC50 |
| TKC066096 | Q9UGC6 | Regulator of G-protein signaling 17 | RGS17 | 6000 | nM | IC50 |
| TKC066096 | P09936 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | UCHL1 | 6800 | nM | IC50 |
| TKC066096 | P15374 | Ubiquitin carboxyl-terminal hydrolase isozyme L3 | UCHL3 | 32100 | nM | IC50 |
| TKC066096 | Q9Y4E8 | Ubiquitin carboxyl-terminal hydrolase 15 | USP15 | 32800 | nM | IC50 |
| TKC066096 | Q9Y5K5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | UCHL5 | 56600 | nM | IC50 |
| Uniport ID | Uniport Name | ICD-11 |
|---|---|---|
| P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
| P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
| P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
| P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
| P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
| P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
| P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
| P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
| P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
| P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
| P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
| P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
| P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
| P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
| P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P17706 | PTN2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P07900 | HS90A_HUMAN | Acute upper respiratory infection [ICD-11: CA07] |
| P07900 | HS90A_HUMAN | Asthma [ICD-11: CA23] |
| P07900 | HS90A_HUMAN | Vasomotor/allergic rhinitis [ICD-11: CA08] |
| P07900 | HS90A_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P07900 | HS90A_HUMAN | Multiple myeloma [ICD-11: 2A83] |
| P07900 | HS90A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P07900 | HS90A_HUMAN | Lung cancer [ICD-11: 2C25] |
| P07900 | HS90A_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P07900 | HS90A_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
| P07900 | HS90A_HUMAN | Stomach cancer [ICD-11: 2B72] |
| P07900 | HS90A_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P07900 | HS90A_HUMAN | Encephalopathy [ICD-11: 8E47] |
| P07900 | HS90A_HUMAN | Mature B-cell lymphoma [ICD-11: 2A85] |
| P07900 | HS90A_HUMAN | Melanoma [ICD-11: 2C30] |
| P07900 | HS90A_HUMAN | Neuropathy [ICD-11: 8C0Z] |
| P07900 | HS90A_HUMAN | Ovarian cancer [ICD-11: 2C73] |
| P07900 | HS90A_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| P07900 | HS90A_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
| P07900 | HS90A_HUMAN | Unspecific body region injury [ICD-11: ND56] |
| P07900 | HS90A_HUMAN | Acute upper respiratory infection [ICD-11: CA07] |
| P07900 | HS90A_HUMAN | Asthma [ICD-11: CA23] |
| P07900 | HS90A_HUMAN | Vasomotor/allergic rhinitis [ICD-11: CA08] |
| P07900 | HS90A_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P07900 | HS90A_HUMAN | Multiple myeloma [ICD-11: 2A83] |
| P07900 | HS90A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P07900 | HS90A_HUMAN | Lung cancer [ICD-11: 2C25] |
| P07900 | HS90A_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P07900 | HS90A_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
| P07900 | HS90A_HUMAN | Stomach cancer [ICD-11: 2B72] |
| P07900 | HS90A_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P07900 | HS90A_HUMAN | Encephalopathy [ICD-11: 8E47] |
| P07900 | HS90A_HUMAN | Mature B-cell lymphoma [ICD-11: 2A85] |
| P07900 | HS90A_HUMAN | Melanoma [ICD-11: 2C30] |
| P07900 | HS90A_HUMAN | Neuropathy [ICD-11: 8C0Z] |
| P07900 | HS90A_HUMAN | Ovarian cancer [ICD-11: 2C73] |
| P07900 | HS90A_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| P07900 | HS90A_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
| P07900 | HS90A_HUMAN | Unspecific body region injury [ICD-11: ND56] |
| O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
| O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
| P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
| P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
| P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
| P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
| P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
| P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
| P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
| P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
| P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
| P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
| P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
| Q14191 | WRN_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
| Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
| Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
| Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
| Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
| Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
| Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
| Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
| Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
| Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
| Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
| Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P37840 | SYUA_HUMAN | Parkinsonism [ICD-11: 8A00] |
| P37840 | SYUA_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P37840 | SYUA_HUMAN | Autonomic nervous system disorder [ICD-11: 8D87] |
| Q13526 | PIN1_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q13526 | PIN1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
| O14746 | TERT_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| O14746 | TERT_HUMAN | Colorectal cancer [ICD-11: 2B91] |
| O14746 | TERT_HUMAN | Liver cancer [ICD-11: 2C12] |
| O14746 | TERT_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O14746 | TERT_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
| O14746 | TERT_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| O14746 | TERT_HUMAN | Lung cancer [ICD-11: 2C25] |
| O14746 | TERT_HUMAN | Multiple myeloma [ICD-11: 2A83] |
| O14746 | TERT_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
| O14746 | TERT_HUMAN | Myeloproliferative neoplasm [ICD-11: 2A20] |
| O14746 | TERT_HUMAN | Thrombocytosis [ICD-11: 3B63] |
| O14746 | TERT_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| O14746 | TERT_HUMAN | Melanoma [ICD-11: 2C30] |
| O14746 | TERT_HUMAN | Ovarian cancer [ICD-11: 2C73] |
| O14746 | TERT_HUMAN | Glaucoma [ICD-11: 9C61] |
| O14746 | TERT_HUMAN | Head and neck cancer [ICD-11: 2D42] |
| O14746 | TERT_HUMAN | Liver cancer [ICD-11: 2C12] |
| O14746 | TERT_HUMAN | Brain cancer [ICD-11: 2A00] |
| O14746 | TERT_HUMAN | Prostate cancer [ICD-11: 2C82] |
| O14746 | TERT_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q06124 | PTN11_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O75604 | UBP2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| P04608 | TAT_HV1H2 | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
| P04608 | TAT_HV1H2 | Rheumatoid arthritis [ICD-11: FA20] |
| P04608 | TAT_HV1H2 | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
| P11413 | G6PD_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P11413 | G6PD_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
| P11413 | G6PD_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
| Q9NR96 | TLR9_HUMAN | Colorectal cancer [ICD-11: 2B91] |
| Q9NR96 | TLR9_HUMAN | Hepatitis virus infection [ICD-11: 1E50-1E51] |
| Q9NR96 | TLR9_HUMAN | Melanoma [ICD-11: 2C30] |
| Q9NR96 | TLR9_HUMAN | Metastatic lymph node neoplasm [ICD-11: 2D60] |
| Q9NR96 | TLR9_HUMAN | Prostate cancer [ICD-11: 2C82] |
| Q9NR96 | TLR9_HUMAN | Skin disease [ICD-11: EA00-EM0Z] |
| Q9NR96 | TLR9_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q9NR96 | TLR9_HUMAN | Squamous cell carcinoma [ICD-11: 2B60-2D01] |
| Q9NR96 | TLR9_HUMAN | Asthma [ICD-11: CA23] |
| Q9NR96 | TLR9_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| Q9NR96 | TLR9_HUMAN | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
| Q9NR96 | TLR9_HUMAN | Indeterminate colitis [ICD-11: DD72] |
| Q9NR96 | TLR9_HUMAN | Leukaemia [ICD-11: 2A60-2B33] |
| Q9NR96 | TLR9_HUMAN | Psoriasis [ICD-11: EA90] |
| Q9NR96 | TLR9_HUMAN | Renal cell carcinoma [ICD-11: 2C90] |
| Q9NR96 | TLR9_HUMAN | Sepsis [ICD-11: 1G40-1G41] |
| Q9NR96 | TLR9_HUMAN | Vasomotor/allergic rhinitis [ICD-11: CA08] |
| Q9NR96 | TLR9_HUMAN | Autoimmune disease [ICD-11: 4A40-4A45] |
| Q9NR96 | TLR9_HUMAN | Brain cancer [ICD-11: 2A00] |
| Q9NR96 | TLR9_HUMAN | Influenza [ICD-11: 1E30-1E32] |
| Q9NR96 | TLR9_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q9NR96 | TLR9_HUMAN | Lupus erythematosus [ICD-11: 4A40] |
| Q9NR96 | TLR9_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
| Q9NR96 | TLR9_HUMAN | Diffuse large B-cell lymphoma [ICD-11: 2A81] |
| Q9NR96 | TLR9_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
| Q9NR96 | TLR9_HUMAN | Parkinsonism [ICD-11: 8A00] |
| Q9NR96 | TLR9_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| Q9NR96 | TLR9_HUMAN | Spine/trunk injury [ICD-11: ND51] |
| P09936 | UCHL1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |